Cargando…

COVID-19: RISCOS DA AUTO-HEMOTERAPIA

Detalles Bibliográficos
Autores principales: Amorim, D.S., Lima, F.L.O., Costa, E.A.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Editora Ltda. 2020
Materias:
889
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604072/
http://dx.doi.org/10.1016/j.htct.2020.10.891
_version_ 1783604061855023104
author Amorim, D.S.
Lima, F.L.O.
Costa, E.A.S.
author_facet Amorim, D.S.
Lima, F.L.O.
Costa, E.A.S.
author_sort Amorim, D.S.
collection PubMed
description
format Online
Article
Text
id pubmed-7604072
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Editora Ltda.
record_format MEDLINE/PubMed
spelling pubmed-76040722020-11-02 COVID-19: RISCOS DA AUTO-HEMOTERAPIA Amorim, D.S. Lima, F.L.O. Costa, E.A.S. Hematol Transfus Cell Ther 889 Published by Elsevier Editora Ltda. 2020-11 2020-10-31 /pmc/articles/PMC7604072/ http://dx.doi.org/10.1016/j.htct.2020.10.891 Text en Copyright © 2020 Published by Elsevier Editora Ltda. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle 889
Amorim, D.S.
Lima, F.L.O.
Costa, E.A.S.
COVID-19: RISCOS DA AUTO-HEMOTERAPIA
title COVID-19: RISCOS DA AUTO-HEMOTERAPIA
title_full COVID-19: RISCOS DA AUTO-HEMOTERAPIA
title_fullStr COVID-19: RISCOS DA AUTO-HEMOTERAPIA
title_full_unstemmed COVID-19: RISCOS DA AUTO-HEMOTERAPIA
title_short COVID-19: RISCOS DA AUTO-HEMOTERAPIA
title_sort covid-19: riscos da auto-hemoterapia
topic 889
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604072/
http://dx.doi.org/10.1016/j.htct.2020.10.891
work_keys_str_mv AT amorimds covid19riscosdaautohemoterapia
AT limaflo covid19riscosdaautohemoterapia
AT costaeas covid19riscosdaautohemoterapia